Zimmer Biomet Holdings

Zimmer Biomet Holdings

Health Care Equipment & Supplies
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

$16.8B

Market Cap • 10/2/2026

2001

(25 years)

Founded

2001

(25 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

1,3

P/S

2

P/EBITDA

7,3

P/OCF

9,7

P/FCF

14

P/E

21,5

BVPS

66,2

EPS

4,1

Market Cap

Market Cap

16,8B

EV

23,9B

EV/Revenue

2,8

EV/EBITDA

10,3

EV/EBIT

19,8

Payout

Dividend Per Share

1

Dividend Yield

1,1%

Buyback Yield

4,3%

Total Yield

5,3%

Dividend Yield 5Y

1%

Payout

23,4%

Retained Earnings

12B

Profitability

Gross Margin

69,9%

EBITDA Margin

27,2%

EBIT Margin

14,2%

Net Margin

9,5%

D&A/EBITDA

29,4%

R&D/Revenue

5,2%

Capex/Revenue

6,4%

Capex/D&A

49%

Capex/OCF

31,2%

SBC/OCF

5,6%

% PPE

9,8%

% Goodwill

43,5%

ROE

6,4%

ROIC

5,1%

Growth

CAGR Revenue 5Y

2,9%

CAGR EPS 5Y

-1,2%

CAGR OCF 5Y

56,3%

Leverage

N.D./EBITDA

3,1

Debt/Equity

0%

Current Ratio

1,7

Quick Ratio

0,7

Interest Coverage

417%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium